These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21252028)

  • 1. Tools & techniques: PCI for acute MI tips and tricks.
    Dudek D; Dziewierz A; Mielecki W
    EuroIntervention; 2011 Feb; 6(7):900-1. PubMed ID: 21252028
    [No Abstract]   [Full Text] [Related]  

  • 2. Tirofiban for catheter intervention in acute myocardial infarction?
    Büttner HJ; Neumann FJ
    Eur Heart J; 2004 May; 25(10):807-9. PubMed ID: 15140527
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.
    Zaman AG
    N Engl J Med; 2003 Nov; 349(22):2167-9; author reply 2167-9. PubMed ID: 14658128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Variety and selection of thrombolytic agents].
    Arima K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():435-40. PubMed ID: 12735011
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy: management of acute myocardial infarction in the new millennium.
    Moliterno DJ
    J Emerg Med; 2000 Oct; 19(3 Suppl):33S-38S. PubMed ID: 11050382
    [No Abstract]   [Full Text] [Related]  

  • 6. STEMI interventions--a review of relevant clinical trials.
    Mehta S; Patlola RR; Cohen S; Falcao E; Flores AI; Soles EO
    Indian Heart J; 2009; 61(2):191-206. PubMed ID: 20039507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two treatments for heart attack. Angioplasty or clot-busting drugs: who benefits from which therapy? Time is of the essence in both.
    Duke Med Health News; 2007 Oct; 13(10):1, 11. PubMed ID: 18277425
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of acute myocardial infarction: the best reperfusion strategy. Opinion of the clinical cardiologist].
    Savonitto S; Schirru M; Fusco R; Klugmann S
    Ital Heart J; 2002 Oct; 3 Suppl 6():9S-17S. PubMed ID: 12422807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute myocardial infarction: thrombolysis].
    Branzi A; Ortolani P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):711-5. PubMed ID: 12497809
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Care of ST elevated myocardial infarction patients in Vendée in 2008: observational and descriptive study].
    Trebouet E; Fradin P; Orion L; Dimet J
    Ann Cardiol Angeiol (Paris); 2010 Aug; 59(4):209-13. PubMed ID: 20674885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myocardial infarction: thrombolysis, angioplasty or stenting.
    Ebersole DG; Vlietstra RE
    Indian Heart J; 1998 Oct; 50 Suppl 1():40-4. PubMed ID: 9824906
    [No Abstract]   [Full Text] [Related]  

  • 16. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute coronary syndromes: an update.
    Fox KA
    Heart; 2004 Jun; 90(6):698-706. PubMed ID: 15145891
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
    Antman EM; Van de Werf F
    Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolysis or primary PCI in myocardial infarction.
    Auer J; Berent R; Gurtner F
    N Engl J Med; 2013 Jul; 369(3):280; discussion page 281. PubMed ID: 23863058
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolysis or primary PCI in myocardial infarction.
    Bogaty P; Brophy JM
    N Engl J Med; 2013 Jul; 369(3):279; discussion page 281. PubMed ID: 23863057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.